{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:23:13Z","timestamp":1790644993177,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jogc.2018.09.018","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T13:44:38Z","timestamp":1552571078000},"page":"505-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["No. 376-Magnesium Sulphate for Fetal Neuroprotection"],"prefix":"10.1016","volume":"41","author":[{"given":"Laura A.","family":"Magee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane A.","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Sawchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Synnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2018.09.018_bib0001","series-title":"Canadian perinatal health report","year":"2008"},{"key":"10.1016\/j.jogc.2018.09.018_bib0002","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.semperi.2016.09.002","article-title":"Early neurodevelopmental outcomes of extremely preterm infants","volume":"40","author":"Rogers","year":"2016","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/1471-0528.14832","article-title":"Cognitive, motor, behavioural andacademic performances of children born preterm: a meta- analysis andsystematic review involving 64 061 children","volume":"125","author":"Allotey","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.09.018_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpeds.2008.08.020","article-title":"Increased risk of adverse neurological development for late preterm infants","volume":"154","author":"Petrini","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0005","first-page":"8","article-title":"A report: the definition and classification of cerebral palsy April 2006","volume":"109","author":"Rosenbaum","year":"2007","journal-title":"Dev Med Child Neurol Suppl"},{"key":"10.1016\/j.jogc.2018.09.018_bib0006","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamapediatrics.2017.1689","article-title":"Early, accurate diagnosis and early intervention in cerebral palsy. Advances in diagnosis and treatment","volume":"171","author":"Novak","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0007","unstructured":"Centers for Disease Control and Prevention. Cerebral Palsy. Available at: http:\/\/www.cdc.gov\/ncbddd\/dd\/ddcp.htm. Accessed on October 19, 2018."},{"key":"10.1016\/j.jogc.2018.09.018_bib0008","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJMoa0706475","article-title":"Long-term medical and social consequences of preterm birth","volume":"359","author":"Moster","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2018.09.018_bib0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-3016.1992.tb00769.x","article-title":"Survival and cerebral palsy in low birthweight infants: implications for perinatal care","volume":"6","author":"Stanley","year":"1992","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-3016.2002.00408.x","article-title":"Analysis by gestational age of cerebral palsy in singleton births in north-east England 1970-94","volume":"16","author":"Drummond","year":"2002","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0011","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1136\/fn.79.1.F21","article-title":"Epidemiology of cerebral palsy in England and Scotland, 1984-9","volume":"79","author":"Pharoah","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jogc.2018.09.018_bib0012","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.110.6.1220","article-title":"Trends in the prevalence of cerebral palsy in a population-based study","volume":"110","author":"Winter","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2018.09.018_bib0013","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/bmj.307.6914.1239","article-title":"Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s","volume":"307","author":"Petterson","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2018.09.018_bib0014","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/GRF.0b013e3181870922","article-title":"Trends in the rates of cerebral palsy associated with neonatal intensive care of preterm children","volume":"51","author":"Hack","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0015","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1001\/jama.297.24.2733","article-title":"Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years","volume":"297","author":"Robertson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2018.09.018_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1651-2227.2001.tb00303.x","article-title":"Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94","volume":"90","author":"Hagberg","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0017","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment\u2013United States, 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jogc.2018.09.018_bib0018","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/AOG.0000000000000748","article-title":"Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis","volume":"125","author":"Sotiriadis","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0019","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/siny.2001.0065","article-title":"Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective","volume":"6","author":"O'Shea","year":"2001","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0020","first-page":"571","article-title":"Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g","volume":"72","author":"Leviton","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/jpme.1987.15.4.333","article-title":"Incidence and prediction of periventricular-intraventricular hemorrhage in very preterm infants","volume":"15","author":"van de Bor","year":"1987","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogc.2018.09.018_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","article-title":"Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?","volume":"95","author":"Nelson","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2018.09.018_bib0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-3016.1992.tb00774.x","article-title":"The California Cerebral Palsy Project","volume":"6","author":"Grether","year":"1992","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/088307389200700113","article-title":"Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies","volume":"7","author":"Kuban","year":"1992","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mob.2000.106581","article-title":"Magnesium sulfate fortocolysis and risk of spastic cerebral palsy in premature children borntowomen without preeclampsia","volume":"183","author":"Grether","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0026","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/oxfordjournals.aje.a009458","article-title":"Prenatal events and the risk of cerebralpalsy in very low birth weight infants","volume":"147","author":"O'Shea","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0027","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/jama.1996.03540220029026","article-title":"Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years","volume":"276","author":"Schendel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2018.09.018_bib0028","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2018.09.018_bib0029","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(95)91034-4","article-title":"Which anticonvulsant for women with eclampsia\u2014evidence from the Collaborative Eclampsia Trial","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2018.09.018_bib0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF02723017","article-title":"Neuronal protection with magnesium","volume":"68","author":"Gathwala","year":"2001","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0031","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00008480-199912000-00002","article-title":"Causes of cerebral palsy","volume":"11","author":"Nelson","year":"1999","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0032","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ajog.2010.01.022","article-title":"Magnesium sulfate reduces inflammation-associated brain injury in fetal mice","volume":"202","author":"Burd","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0033","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(90)90569-U","article-title":"Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats","volume":"109","author":"McDonald","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jogc.2018.09.018_bib0034","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2018.09.018_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","article-title":"Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial","volume":"114","author":"Marret","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.09.018_bib0036","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/mob.2002.123544","article-title":"Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants","volume":"186","author":"Mittendorf","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0037","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2018.09.018_bib0038","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-0528.2006.01165.x","article-title":"The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months","volume":"114","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.09.018_bib0039","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2009.04.005","article-title":"Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis","volume":"200","author":"Conde-Agudelo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/AOG.0b013e3181ae98c2","article-title":"Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis","volume":"114","author":"Costantine","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogc.2018.09.018_bib0041","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","author":"Doyle","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2018.09.018_bib0042","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/aogs.12018","article-title":"Does antenatal magnesium sulfate prevent ceberal palsy in preterm infants? The final trial?","volume":"91","author":"Huusom","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2018.09.018_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.2010.02782.x","article-title":"Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants\u2013but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis","volume":"118","author":"Huusom","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.09.018_bib0044","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2393-13-91","article-title":"Magnesium sulphate to 30 to 34 weeks' gestational age: neuroprotection trial(MAGENTA)\u2013study protocol","volume":"13","author":"Crowther","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2018.09.018_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002398","article-title":"Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analyisis","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jogc.2018.09.018_bib0046","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/1472-6963-13-527","article-title":"Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis","volume":"13","author":"Bickford","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jogc.2018.09.018_bib0047","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajog.2011.09.004","article-title":"Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis","volume":"205","author":"Cahill","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0048","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.09.018_bib0049","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(97)24047-X","article-title":"Is tocolytic magnesium sulphate associated with increased total paediatric mortality?","volume":"350","author":"Mittendorf","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2018.09.018_bib0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1471-0528.2006.01166.x","article-title":"The Magpie trial: arandomised trial comparing magnesium sulphate with placebo for pre-eclampsia.Outcome for women at 2 years","volume":"114","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.09.018_bib0051","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2015.06.067","article-title":"Antenatal magnesium and cerebral palsy in preterm infants","volume":"167","author":"Hirtz","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0052","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jama.2014.11189","article-title":"School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo","volume":"312","author":"Doyle","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2018.09.018_bib0053","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpeds.2014.04.007","article-title":"School-age outcomes following a randomized controlled trial of magnesium sulphate for neuroprotection of preterm infants","volume":"165","author":"Chollat","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0054","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13012-017-0702-9","article-title":"MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP) - implementation of a national guideline in Canada","volume":"13","author":"De Silva","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.jogc.2018.09.018_bib0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/AOG.0000000000000467","article-title":"Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes","volume":"124","author":"McPherson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0056","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.1101765","article-title":"Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism","volume":"188","author":"Sugimoto","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0057","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1701-2163(16)30047-0","article-title":"Magnesium sulphate for eclampsia and fetal neuroprotection: a comparative analysis of protocols across Canadian tertiary perinatal centres","volume":"37","author":"De Silva","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.09.018_bib0058","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1701-2163(15)30382-0","article-title":"Effect of magnesium sulphate on fetal heart rate parameters: a systematic review","volume":"36","author":"Nensi","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.09.018_bib0059","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1542\/peds.47.3.501","article-title":"The clinical and biochemical effects of excess magnesium in the newborn","volume":"47","author":"Lipsitz","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2018.09.018_bib0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpeds.2011.09.016","article-title":"Association of cord blood magnesium concentration and neonatal resuscitation","volume":"160","author":"Johnson","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0061","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1136\/archdischild-2013-305884","article-title":"Intrapartum magnesium sulfate and need for intensive delivery room resuscitation","volume":"100","author":"Weisz","year":"2015","journal-title":"Arch Dis Child Neonatal Ed"},{"key":"10.1016\/j.jogc.2018.09.018_bib0062","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajog.2015.05.052","article-title":"Does magnesium exposure affect neonatal resuscitation?","volume":"213","author":"Drassinower","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0063","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.rchipe.2015.11.006","article-title":"[Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection]","volume":"87","author":"Lloreda-Garcia","year":"2016","journal-title":"Rev Chil Pediatr"},{"key":"10.1016\/j.jogc.2018.09.018_bib0064","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/jp.2011.168","article-title":"Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery-neonatal cardiovascular effects","volume":"32","author":"Paradisis","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jp.7211663","article-title":"Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extermely low birth weight infants","volume":"27","author":"Del Moral","year":"2007","journal-title":"J Perinatol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0066","series-title":"Magnesium Sulphate for Fetal Neuroprotection to Prevent Cerebral Palsy (MAG-CP)","year":"2017"},{"key":"10.1016\/j.jogc.2018.09.018_bib0067","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1701-2163(16)32615-9","article-title":"Fetal health surveillance: antepartum and intrapartum consensus guideline","volume":"29","author":"Liston","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.09.018_bib0068","series-title":"Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: national clinical practice guidelines","year":"2010"},{"key":"10.1016\/j.jogc.2018.09.018_bib0069","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0b013e3181d4ffa5","article-title":"Committee opinion no. 455: magnesium sulfate before anticipated preterm birth for neuroprotection","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.09.018_bib0070","series-title":"WHO Recommendations on Interventions to Improve Preterm Birth Outcomes","year":"2015"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318307606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318307606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:33:27Z","timestamp":1761665607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216318307606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1701216318307606"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2018.09.018","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No. 376-Magnesium Sulphate for Fetal Neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2018.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}